The Patent Finder

Terms ending in 2029

Yeda Research and Development Co. Ltd.

Every in-force patent on Yeda Research and Development Co. Ltd.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,155,488Method and Device for Monitoring Breastfeeding
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In forceMedium confidence
US 9,867,576Computer-Accessible Medium, System and Method for Assessing Effect of a Stimulus Using Intersubject Correlation
In force
 · High confidence
Yeda Research and Development Co., Ltd. at the Weizmann Institute of ScienceIn forceHigh confidence
US 8,331,017Crystal for Optical Conversion
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 8,324,355Antibodies and Pharmaceutical Compositions Containing Same Useful for Inhibiting Activity of Metalloproteins
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 8,521,272Method and Device for Monitoring Breastfeeding
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
US 8,889,865Process for Preparing Amines from Alcohols and Ammonia
Grace period ended Nov 18, 2026 · lapse expected
 · Low confidence
Yeda Research and Development Co. Ltd.Grace period ended Nov 18, 2026
lapse expected
Low confidence
US 10,512,699Optical Method for the Detection of Alzheimer's Disease Using Curcumin
In force
 · Medium confidence
Cedars-Sinai Medical CenterIn forceMedium confidence
US 9,109,029Compositions Comprising Soluble CD84 or ANTI-CD84 Antibodies and Methods for Diagnosing and Treating B-Cll
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In forceMedium confidence
US 9,421,228Use of Anti Third Party Central Memory T Cells for Anti-Leukemia/Lymphoma Treatment
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In forceMedium confidence
US 9,738,872Anti Third Party Central Memory T Cells, Methods of Producing Same and Use of Same in Transplantation and Disease Treatment
In force
 · High confidence
Yeda Research and Development Co. Ltd.In forceHigh confidence
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited